PL2975023T3 - Ester kwasu guanidynobenzoesowego - Google Patents
Ester kwasu guanidynobenzoesowegoInfo
- Publication number
- PL2975023T3 PL2975023T3 PL14763790T PL14763790T PL2975023T3 PL 2975023 T3 PL2975023 T3 PL 2975023T3 PL 14763790 T PL14763790 T PL 14763790T PL 14763790 T PL14763790 T PL 14763790T PL 2975023 T3 PL2975023 T3 PL 2975023T3
- Authority
- PL
- Poland
- Prior art keywords
- acid ester
- guanidinobenzoic acid
- guanidinobenzoic
- ester
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013050011 | 2013-03-13 | ||
| PCT/JP2014/056601 WO2014142219A1 (ja) | 2013-03-13 | 2014-03-13 | グアニジノ安息香酸エステル化合物 |
| EP14763790.4A EP2975023B1 (en) | 2013-03-13 | 2014-03-13 | Guanidinobenzoic acid ester compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2975023T3 true PL2975023T3 (pl) | 2018-11-30 |
Family
ID=51536870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14763790T PL2975023T3 (pl) | 2013-03-13 | 2014-03-13 | Ester kwasu guanidynobenzoesowego |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US9969709B2 (pl) |
| EP (1) | EP2975023B1 (pl) |
| JP (1) | JP6314129B2 (pl) |
| KR (1) | KR102145649B1 (pl) |
| CN (1) | CN105051008B (pl) |
| AU (1) | AU2014230583B2 (pl) |
| BR (1) | BR112015022762B1 (pl) |
| CA (1) | CA2905606C (pl) |
| CY (1) | CY1120552T1 (pl) |
| DK (1) | DK2975023T3 (pl) |
| ES (1) | ES2684045T3 (pl) |
| HK (1) | HK1216246A1 (pl) |
| HR (1) | HRP20181371T1 (pl) |
| HU (1) | HUE039526T2 (pl) |
| IL (1) | IL241541B (pl) |
| LT (1) | LT2975023T (pl) |
| MX (1) | MX373838B (pl) |
| MY (1) | MY194604A (pl) |
| PH (1) | PH12015502023B1 (pl) |
| PL (1) | PL2975023T3 (pl) |
| PT (1) | PT2975023T (pl) |
| RS (1) | RS57568B1 (pl) |
| RU (1) | RU2661895C2 (pl) |
| SG (2) | SG11201507411TA (pl) |
| SI (1) | SI2975023T1 (pl) |
| SM (1) | SMT201800440T1 (pl) |
| TR (1) | TR201809418T4 (pl) |
| TW (1) | TWI666196B (pl) |
| UA (1) | UA118668C2 (pl) |
| WO (1) | WO2014142219A1 (pl) |
| ZA (1) | ZA201506745B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2975023T3 (pl) | 2013-03-13 | 2018-11-30 | Takeda Pharmaceutical Company Limited | Ester kwasu guanidynobenzoesowego |
| US9346776B2 (en) * | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP2018080109A (ja) * | 2015-03-16 | 2018-05-24 | 武田薬品工業株式会社 | 治療剤 |
| WO2016158788A1 (ja) * | 2015-03-27 | 2016-10-06 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| CN105218289B (zh) * | 2015-10-15 | 2017-08-01 | 浙江大学 | 一种不饱和脂肪酸原位加氢脱羧制备长链烷烃的方法 |
| CN111542511A (zh) | 2017-11-02 | 2020-08-14 | 宇部兴产株式会社 | 蛋白分解酶的双头型抑制剂 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5289640A (en) | 1976-01-21 | 1977-07-27 | Ono Pharmaceut Co Ltd | Guanidinobenzoic acid derivatives, and antiplasmin agents and remedies for pancreas diseases containing the said guanidinobensolc acid deriv atives |
| AU527371B2 (en) | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
| JPS5753454A (en) | 1980-09-16 | 1982-03-30 | Torii Yakuhin Kk | Guanidinobenzoate and anticomplementary agent |
| US5116985A (en) | 1989-12-28 | 1992-05-26 | Snow Brand Milk Products Co., Ltd. | Isoquinoline derivatives and salts thereof |
| JP2886586B2 (ja) | 1989-12-28 | 1999-04-26 | 雪印乳業株式会社 | 新規グアニジノ安息香酸誘導体及びその酸付加塩 |
| JPH0446148A (ja) | 1990-06-08 | 1992-02-17 | Asahi Chem Ind Co Ltd | ４―グアニジノ安息香酸フェニルエステル誘導体およびそれらを含有する蛋白分解酵素阻害剤 |
| JPH06192085A (ja) | 1992-08-31 | 1994-07-12 | Yuji Inada | ダニアレルギー治療剤 |
| WO1994013631A1 (en) | 1992-12-10 | 1994-06-23 | Teikoku Chemical Industries Co., Ltd. | Propionic acid derivative |
| JPH0753500A (ja) | 1993-08-16 | 1995-02-28 | Sanwa Kagaku Kenkyusho Co Ltd | グアニジノ安息香酸誘導体及びこれらを有効成分とする蛋白分解酵素阻害剤 |
| JPH0848664A (ja) | 1994-08-05 | 1996-02-20 | Hisamitsu Pharmaceut Co Inc | 新規なグアニジノ安息香酸エステル誘導体 |
| JPH09124571A (ja) * | 1995-11-01 | 1997-05-13 | Japan Tobacco Inc | アミド化合物及びその用途 |
| WO1997037969A1 (fr) | 1996-04-10 | 1997-10-16 | Ono Pharmaceutical Co., Ltd. | Inhibiteur de tryptase derives de guanidino |
| JPH10101556A (ja) | 1996-09-27 | 1998-04-21 | Ono Pharmaceut Co Ltd | ファクターｄ阻害剤 |
| JPH10251239A (ja) | 1997-03-14 | 1998-09-22 | Mochida Pharmaceut Co Ltd | 新規４ｈ−３，１−ベンゾオキサジン−４−オン誘導体 |
| JPH10306025A (ja) | 1997-05-07 | 1998-11-17 | Touin Yokohama Univ | 花粉プロテアーゼ阻害剤 |
| EP1815865A4 (en) | 2004-11-08 | 2010-08-25 | Ono Pharmaceutical Co | THERAPEUTIC AGENT AGAINST DIABETES WITH A PROTEASE-INHIBITING COMPOUND |
| WO2006050999A2 (en) | 2004-11-15 | 2006-05-18 | Obe Therapy Biotechnology S.A.S | Methods of reducing body fat |
| WO2006057551A1 (en) | 2004-11-26 | 2006-06-01 | N.V. Nutricia | Infant nutrition with protease inhibitor |
| CA2593858A1 (en) | 2005-01-31 | 2006-08-10 | Min Ge | Antidiabetic bicyclic compounds |
| JP2009523726A (ja) | 2006-01-12 | 2009-06-25 | メルク エンド カムパニー インコーポレーテッド | ヒドロキシアルキルアリールアミド誘導体 |
| WO2009071601A1 (en) | 2007-12-03 | 2009-06-11 | Obe Therapy Biotechnology | Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| CN102822154B (zh) | 2009-12-07 | 2016-06-01 | 味之素株式会社 | 杂芳基羧酸酯衍生物 |
| ES2618024T3 (es) | 2011-06-07 | 2017-06-20 | Ea Pharma Co., Ltd. | Derivado de éster de ácido carboxílico heterocíclico |
| WO2013039187A1 (ja) * | 2011-09-15 | 2013-03-21 | アステラス製薬株式会社 | グアニジノ安息香酸化合物 |
| CN104159598A (zh) | 2012-01-03 | 2014-11-19 | 奥拉姆德有限公司 | 治疗糖尿病的方法和组合物 |
| US9024044B2 (en) | 2012-06-14 | 2015-05-05 | Ajinomoto Co., Inc. | Heteroarylcarboxylic acid ester derivative |
| US20150335715A1 (en) | 2013-01-03 | 2015-11-26 | Oramed Ltd. | Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof |
| WO2014138484A1 (en) | 2013-03-08 | 2014-09-12 | Amgen Inc. | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| PL2975023T3 (pl) | 2013-03-13 | 2018-11-30 | Takeda Pharmaceutical Company Limited | Ester kwasu guanidynobenzoesowego |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US9346776B2 (en) * | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
-
2014
- 2014-03-13 PL PL14763790T patent/PL2975023T3/pl unknown
- 2014-03-13 MY MYPI2015703099A patent/MY194604A/en unknown
- 2014-03-13 MX MX2015012604A patent/MX373838B/es active IP Right Grant
- 2014-03-13 SG SG11201507411TA patent/SG11201507411TA/en unknown
- 2014-03-13 JP JP2015505541A patent/JP6314129B2/ja active Active
- 2014-03-13 TW TW103109057A patent/TWI666196B/zh active
- 2014-03-13 PT PT147637904T patent/PT2975023T/pt unknown
- 2014-03-13 DK DK14763790.4T patent/DK2975023T3/en active
- 2014-03-13 US US14/775,274 patent/US9969709B2/en active Active
- 2014-03-13 SG SG10201707504VA patent/SG10201707504VA/en unknown
- 2014-03-13 SM SM20180440T patent/SMT201800440T1/it unknown
- 2014-03-13 SI SI201430865T patent/SI2975023T1/sl unknown
- 2014-03-13 CN CN201480014813.4A patent/CN105051008B/zh active Active
- 2014-03-13 ES ES14763790.4T patent/ES2684045T3/es active Active
- 2014-03-13 BR BR112015022762-7A patent/BR112015022762B1/pt active IP Right Grant
- 2014-03-13 TR TR2018/09418T patent/TR201809418T4/tr unknown
- 2014-03-13 KR KR1020157027906A patent/KR102145649B1/ko active Active
- 2014-03-13 LT LTEP14763790.4T patent/LT2975023T/lt unknown
- 2014-03-13 RU RU2015143562A patent/RU2661895C2/ru active
- 2014-03-13 EP EP14763790.4A patent/EP2975023B1/en active Active
- 2014-03-13 AU AU2014230583A patent/AU2014230583B2/en active Active
- 2014-03-13 UA UAA201509922A patent/UA118668C2/uk unknown
- 2014-03-13 HU HUE14763790A patent/HUE039526T2/hu unknown
- 2014-03-13 WO PCT/JP2014/056601 patent/WO2014142219A1/ja active Application Filing
- 2014-03-13 CA CA2905606A patent/CA2905606C/en active Active
- 2014-03-13 RS RS20180861A patent/RS57568B1/sr unknown
-
2015
- 2015-09-09 PH PH12015502023A patent/PH12015502023B1/en unknown
- 2015-09-10 IL IL241541A patent/IL241541B/en active IP Right Grant
- 2015-09-11 ZA ZA2015/06745A patent/ZA201506745B/en unknown
-
2016
- 2016-04-13 HK HK16104215.3A patent/HK1216246A1/zh unknown
-
2018
- 2018-08-09 CY CY20181100832T patent/CY1120552T1/el unknown
- 2018-08-27 HR HRP20181371TT patent/HRP20181371T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222136A1 (zh) | 交聯的絲-透明質酸組合物 | |
| DK2850067T3 (da) | Carboxylsyreforbindelser | |
| DK3620534T3 (da) | Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer | |
| DK2875743T3 (da) | Kittel | |
| EP2926266A4 (en) | CLOUD OBJECT | |
| DK3004155T3 (da) | Peptidforbindelse | |
| DK2956698T3 (da) | Bindestrimler | |
| DK2943561T3 (da) | Fotobioreaktor | |
| HRP20181371T1 (hr) | Spoj estera gvanidinbenzojeve kiseline | |
| DK2946640T3 (da) | Langmuir-probe | |
| DK2967936T3 (da) | Skrå stent | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| DK3082762T3 (da) | Langtidsvirkende ketoprofensammensætninger | |
| DE112014001252A5 (de) | Aufbissschiene | |
| DK2981168T3 (da) | Laminitiskile | |
| FI10699U1 (fi) | Käämitysjärjestely | |
| DK2824325T3 (da) | Tårnsektionsopbevaring | |
| TH1501005372A (th) | สารประกอบกวานิดิโนเบนโซอิกแอซิดเอสเตอร์ | |
| TH1401006870A (th) | สารประกอบคาร์บอกซิลิคแอซิด | |
| TH1401007860A (th) | สารประกอบไดเมธิล-เบนโซอิค แอซิด | |
| DE112014003213A5 (de) | Flansch | |
| UA29037S (uk) | Фланець | |
| UA29036S (uk) | Фланець | |
| UA26681S (uk) | Фланець | |
| UA27594S (uk) | Фланець |